KANEKO Y, Kato M, Tanaka Y, Inoo M, et al Tocilizumab discontinuation after attaining remission in patients with rheumatoid
arthritis who were treated with tocilizumab alone or in combination with
methotrexate: results from a prospective randomised controlled study (the second
year of the SUR
Ann Rheum Dis. 2018 May 31. pii: annrheumdis-2018-213416.PubMedText formatAbstract available

LISNEY AR, Szelinski F, Reiter K, Burmester GR, et al High maternal expression of SIGLEC1 on monocytes as a surrogate marker of a type
I interferon signature is a risk factor for the development of autoimmune
congenital heart block.
Ann Rheum Dis. 2017;76:1476-1480.PubMedText formatAbstract available

FENT GJ, Greenwood JP, Plein S, Buch MH, et al The role of non-invasive cardiovascular imaging in the assessment of
cardiovascular risk in rheumatoid arthritis: where we are and where we need to
be.
Ann Rheum Dis. 2016 Nov 28. pii: annrheumdis-2016-209744.PubMedText formatAbstract available